Trademark: SYMBRAVO
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for SYMBRAVO
We do not have any records of a proof of use for SYMBRAVO at this moment.
Possible trademark infringements of SYMBRAVO
Basic Information about SYMBRAVO
- Serial Number
- 90482774
- Filing Date
- 22 Jan 2021
- Registration Number
- 7451179
- Registration Date
- 16 Jul 2024
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of SYMBRAVO on the blockchain with WikiTrademarks.io.
- First use of SYMBRAVO anywhere
- SYMBRAVO was first used on 01 Jan 2022 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns SYMBRAVO?
1. Axsome Therapeutics, Inc. New York NY
2. Axsome Therapeutics, Inc. New York NY
3. Axsome Therapeutics, Inc. New York NY
Correspondent
- Brent Johnson Procopio, Cory, Hargreaves & Savitch LLP
- 525 B Street, Suite 2200
- San Diego, CA 92101
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io